Related Experiment Video
Updated: Sep 1, 2025

06:48
Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
Published on: March 23, 2022
2.5K
Thalassemia in Indonesia.
Pustika A Wahidiyat1, Teny T Sari1, Ludi D Rahmartani1
1Department of Child Health, Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Hemoglobin
|August 11, 2022
Summary
Indonesia faces a high burden of thalassemia, with significant numbers of babies born with beta-thalassemia major annually. Optimizing prevention programs is crucial due to treatment challenges and rising healthcare costs.
Area of Science:
- Genetics
- Hematology
- Public Health
Background:
- Indonesia is situated within the 'Thalassemia Belt,' a region with a high prevalence of hemoglobinopathies.
- Approximately 3.0-10.0% of the Indonesian population carry beta-thalassemia (β-thal) and 2.6-11.0% carry alpha-thalassemia (α-thal).
- An estimated 2500 babies are born with beta-thalassemia major (β-TM) annually in Indonesia.
Purpose of the Study:
- To review the current management strategies for beta-thalassemia major in Indonesia.
- To identify challenges in treatment adherence and healthcare system support.
- To propose optimized preventive programs as a sustainable solution.
Main Methods:
- Review of existing literature and healthcare data on thalassemia in Indonesia.
- Analysis of current treatment protocols, including blood transfusions and iron chelation therapy.
- Assessment of hemovigilance systems and drug availability.
Main Results:
- Current β-TM treatment relies on supportive care, facing issues with hemovigilance, transfusion-transmitted infections, and inconsistent iron chelator availability.
- Poor adherence to iron chelation and maintaining adequate hemoglobin levels are significant challenges.
- The rising life expectancy increases the financial burden of thalassemia management.
Conclusions:
- Optimizing preventive programs is the most suitable strategy for addressing the thalassemia burden in Indonesia.
- Improving hemovigilance and ensuring consistent access to iron chelators are critical.
- Addressing adherence issues is essential for effective disease management.
Related Concept Videos
Multiple Allele Traits
34.6K
The Concept of Multiple Allelism
34.6K
Diabetes Mellitus: Overview and Type I Subtype
3.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.0K
Lethal Alleles
15.7K
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
15.7K
Inborn Errors of Metabolism
234
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
234
Incomplete Dominance
25.3K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
25.3K
Translation
143.0K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
143.0K

